Sign in

CIK 0001690585

  • Non-accelerated filer
  • Smaller reporting company

Dianthus Therapeutics, Inc. /DE/

Sign in to watch
Ticker
DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 929-999-4055
Business address
7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
Former names
Magenta Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$15,717,056
in 3 filings, $15.7M under 10b5-1 plans

Net −$15,717,056. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-05-21 Soteropoulos Paula Director Grant or award · Stock Option (Right to Buy) +6,090 6,090
2026-05-08 Soteropoulos Paula Director Exercise or conversion 10b5-1 +599 $8.44 $5K 599
2026-05-08 Soteropoulos Paula Director Sale 10b5-1 −599 $85.47 $51K 0
2026-05-08 Soteropoulos Paula Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −599 0
2026-03-31 Soteropoulos Paula Director Exercise or conversion 10b5-1 +599 $8.44 $5K 599
2026-03-31 Soteropoulos Paula Director Sale 10b5-1 −599 $80.11 $48K 0
2026-03-31 Soteropoulos Paula Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −599 599
2026-03-24 Soteropoulos Paula Director Exercise or conversion 10b5-1 +27,594 $8.44 $233K 27,594
2026-03-24 Soteropoulos Paula Director Sale 10b5-1 −27,594 $78.05 $2.2M 0
2026-03-24 Soteropoulos Paula Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −27,594 1,198
2025-05-22 Soteropoulos Paula Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2024-05-23 Soteropoulos Paula Director Grant or award · Stock Option (Right to Buy) +11,000 11,000
2023-09-11 Soteropoulos Paula Director Grant or award · Stock Option (Right to Buy) +6,500 6,500

Page 1 of 1 · 13 trades